Concentrix (NASDAQ:CNXC) Trading Up 7% – What’s Next?

Concentrix Corporation (NASDAQ:CNXC) shares shot up 7% during trading on Thursday . The company traded as high as $27.18 and last traded at $26.3950. 278,523 shares changed hands during trading, a decline of 81% from the average session volume of 1,469,269 shares. The stock had previously closed at $24.67.

More Concentrix News

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Quarterly dividend announced (0.36/share; ~5.8% yield) gives income-oriented investors a concrete cash return and support under the share price.
• Positive Sentiment: Several firms maintained buy/outperform views despite trimming targets, keeping upside narratives alive (Barrington, Canaccord, Robert W. Baird). This analyst support likely helped stabilize buying interest. Analyst Coverage Summary
• Positive Sentiment: Management highlighted strong AI adoption and growth in banking verticals on the Q1 call, supporting a longer-term revenue/strategy thesis if margins recover. Q1 2026 Earnings Call Highlights
• Neutral Sentiment: Market mention coverage (e.g., Bloomberg “Stock Movers”) increased visibility but is informational rather than directional. Bloomberg Stock Movers
• Neutral Sentiment: Reports on short interest are inconsistent/erroneous in public filings for March (zero/NaN values), so short-squeeze dynamics appear unclear and shouldn’t be over-interpreted at this point.
• Negative Sentiment: Investors reacted to a margin squeeze and cautious 2026 guidance, which were flagged as the primary reasons for an earlier sharp drop in the stock; this guidance uncertainty is a near-term headwind. Why Concentrix Is Down 14%
• Negative Sentiment: Q1 showed an EPS miss (small) and margin pressure; coverage notes the stock hit a one-year low after the earnings surprise, highlighting execution and profitability risks. Sets New 1-Year Low After Earnings Miss
• Negative Sentiment: Critical analyst pieces and downgrades emphasize high leverage, negative Q1 free cash flow and execution risk during a costly AI transition — reasons some investors remain reluctant to buy despite low valuation. Seeking Alpha Downgrade Why I’m Not Buying

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Weiss Ratings downgraded Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a report on Thursday, January 29th. Barrington Research cut their price objective on shares of Concentrix from $62.00 to $38.00 and set an “outperform” rating on the stock in a report on Wednesday. Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Canaccord Genuity Group cut their price target on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Robert W. Baird decreased their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a research note on Wednesday. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $48.50.

Concentrix Price Performance

The stock has a market cap of $1.67 billion, a P/E ratio of -1.26, a P/E/G ratio of 0.28 and a beta of 0.50. The business has a 50 day simple moving average of $35.01 and a 200-day simple moving average of $40.22. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.40 and a current ratio of 1.18.

Concentrix (NASDAQ:CNXC) last released its earnings results on Tuesday, March 24th. The company reported $2.61 EPS for the quarter, missing analysts’ consensus estimates of $2.65 by ($0.04). The business had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.49 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The company’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.79 earnings per share. On average, sell-side analysts forecast that Concentrix Corporation will post 10.11 EPS for the current year.

Concentrix Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 5th. Shareholders of record on Friday, April 24th will be given a $0.36 dividend. The ex-dividend date of this dividend is Friday, April 24th. This represents a $1.44 annualized dividend and a yield of 5.3%. Concentrix’s payout ratio is currently -6.91%.

Insiders Place Their Bets

In related news, CEO Christopher A. Caldwell bought 1,000 shares of Concentrix stock in a transaction dated Thursday, January 29th. The stock was purchased at an average cost of $37.07 per share, with a total value of $37,070.00. Following the transaction, the chief executive officer directly owned 362,075 shares of the company’s stock, valued at approximately $13,422,120.25. The trade was a 0.28% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.90% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Concentrix

Institutional investors have recently bought and sold shares of the company. AQR Capital Management LLC grew its holdings in Concentrix by 25.5% during the second quarter. AQR Capital Management LLC now owns 4,305,469 shares of the company’s stock valued at $226,252,000 after purchasing an additional 875,556 shares during the period. Pzena Investment Management LLC lifted its position in shares of Concentrix by 32.3% during the 4th quarter. Pzena Investment Management LLC now owns 2,927,196 shares of the company’s stock valued at $121,713,000 after buying an additional 714,604 shares during the last quarter. Deprince Race & Zollo Inc. purchased a new position in shares of Concentrix during the 3rd quarter valued at $31,768,000. Dimensional Fund Advisors LP grew its stake in shares of Concentrix by 28.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock worth $103,588,000 after acquiring an additional 551,778 shares during the period. Finally, Alyeska Investment Group L.P. bought a new position in shares of Concentrix during the 4th quarter worth $22,913,000. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.